Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.60 |
| ▸ | CA2 | P00918 | 9/20 | 0.60 |
| ▸ | CA9 | Q16790 | 9/20 | 0.60 |
| ▸ | CA12 | O43570 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | GBA1 | P04062 | 2/20 | 0.47 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.40 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13078711 | 0.88 | ABCB1 (0.49) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL14013405 | 0.87 | MEN1 (0.62) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL12418856 | 0.87 | CA9 (0.60) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL12307301 | 0.86 | MEN1 (0.64) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL10293759 | 0.86 | P2RY6 (0.64) | CA1CA2CA9CA12MEN1 | |
| Tetramethylrhodamine SCHEMBL2054818 | 0.85 | MEN1 (0.71) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL12716296 | 0.85 | P2RY6 (0.62) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL19818214 | 0.84 | CA1 (0.64) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL14291308 | 0.84 | CA1 (0.69) | CA1CA2CA9CA12MEN1 | |
| SCHEMBL14176750 | 0.84 | MEN1 (0.64) | CA1CA2CA9CA12MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8772487-B2 | Fluorogenic hydrazine-substituted compounds | Life Technologies Corporation (US) | 2014-07-08 | — | — | US | disclosed |
| US-20100291547-A1 | FLUOROGENIC HYDRAZINE-SUBSTITUTED COMPOUNDS | Life Technologies Corporation (US) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291547-A1 | FLUOROGENIC HYDRAZINE-SUBSTITUTED COMPOUNDS | ALDH2, ALDH1A2, HLCS | CA1 84/4885CA2 511/4885CA9 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.